More recently, Krumbholz et al. observed elevated levels of CCL19 in CSF of MS patients, where it correlated with IgG levels25, corroborating a previous report where elevated levels of either CCR7 ligand (CCL19 and CCL21) in MS patients correlated weakly with total cell counts24. Here, CCL19 is linked to myeloid sarcoma.